Vaccines based on Nef and on Nef/DeltaV2 Env
- PMID: 16243564
- DOI: 10.1016/j.micinf.2005.07.015
Vaccines based on Nef and on Nef/DeltaV2 Env
Abstract
Modified vaccinia virus Ankara (MVA) is a potent vaccine vector, which proved its safety, immunogenity and efficacy in preclinical and clinical studies. The rational for the development of a vaccine against HIV based on the regulatory protein Nef delivered by MVA combined with a V2-deleted Env protein is discussed.
Similar articles
-
Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 Env.Microbes Infect. 2005 Nov;7(14):1392-9. doi: 10.1016/j.micinf.2005.07.016. Epub 2005 Sep 15. Microbes Infect. 2005. PMID: 16243561
-
Criteria for selection of HIV vaccine candidates--general principles.Microbes Infect. 2005 Nov;7(14):1433-5. doi: 10.1016/j.micinf.2005.07.019. Epub 2005 Sep 15. Microbes Infect. 2005. PMID: 16213181
-
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.J Virol. 2004 Jul;78(14):7490-7. doi: 10.1128/JVI.78.14.7490-7497.2004. J Virol. 2004. PMID: 15220422 Free PMC article.
-
Current approaches to vaccination against human immunodeficiency viruses.Allergol Immunopathol (Madr). 1991 Jan-Feb;19(1):11-3. Allergol Immunopathol (Madr). 1991. PMID: 1719790 Review. No abstract available.
-
Retroviral vectors for HIV immunotherapy.Ann N Y Acad Sci. 1995 Nov 27;772:105-16. doi: 10.1111/j.1749-6632.1995.tb44736.x. Ann N Y Acad Sci. 1995. PMID: 8546383 Review. No abstract available.
Cited by
-
Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines.Vaccine. 2010 Feb 10;28(6):1547-57. doi: 10.1016/j.vaccine.2009.11.056. Epub 2009 Dec 5. Vaccine. 2010. PMID: 19969118 Free PMC article.
-
IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality.PLoS One. 2012;7(5):e37801. doi: 10.1371/journal.pone.0037801. Epub 2012 May 24. PLoS One. 2012. PMID: 22655069 Free PMC article.
-
Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.Am J Infect Dis. 2007;3(4):10.3844/ajidsp.2007.267.275. doi: 10.3844/ajidsp.2007.267.275. Am J Infect Dis. 2007. PMID: 24327810 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical